- Release Date: 14/02/19 09:41
- Summary: PARADIGMS ORPHAN PHASE 2/3 CLINICAL PROGRAM PROGRESSES
- Price Sensitive: Yes
- Download Document 1.85MB
- Forums
- ASX - By Stock
- PAR
- Ann: PARADIGMS ORPHAN PHASE 2/3 CLINICAL PROGRAM PROGRESSES
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.39%
!
30.5¢

Ann: PARADIGMS ORPHAN PHASE 2/3 CLINICAL PROGRAM PROGRESSES
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
0.010(3.39%) |
Mkt cap ! $117.2M |
Open | High | Low | Value | Volume |
30.0¢ | 30.5¢ | 30.0¢ | $44.94K | 147.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 62148 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 201464 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 62148 | 0.300 |
14 | 151913 | 0.295 |
16 | 409809 | 0.290 |
11 | 141744 | 0.285 |
10 | 82979 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 201464 | 3 |
0.315 | 7159 | 4 |
0.320 | 28629 | 4 |
0.325 | 4610 | 1 |
0.330 | 4150 | 1 |
Last trade - 10.25am 13/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |